zoledronic acid has been researched along with Chronic Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gehlen, M; Hinz, C; Lazarescu, AD; Maier, A; Pfeifer, M; Schmidt, N; Schwarz-Eywill, M; Weidemann, HF; Werner, M | 1 |
| Ato, M; Iwagami, M; Kano, S; Ota, N; Seki, T; Yamamoto, K | 1 |
| Arima, S; Hayakawa, K; Hoshinaga, K; Kusaka, M; Maruyama, T; Miyakawa, S; Mori, S; Sasaki, H; Shiroki, R | 1 |
| Chae, YS; Kim, JG; Kim, SN; Kim, YJ; Lee, SJ; Moon, JH; Sohn, SK | 1 |
| Arduino, PG; Broccoletti, R; Dalmasso, P; Mozzati, M; Scoletta, M | 1 |
| Hale, SL; Hwang, H; Kloner, RA; Leeka, J | 1 |
| Hollstein, S; Hölzle, F; Kriwalsky, MS; Kunkel, M; Maurer, P; Rashad, A; Sandulescu, T; Stricker, I | 1 |
| Angus, PW; Byth, K; Crawford, BA; Handelsman, DJ; Kam, C; McCaughan, GW; Pavlovic, J | 1 |
2 trial(s) available for zoledronic acid and Chronic Disease
| Article | Year |
|---|---|
Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients.
Topics: Adolescent; Adult; Aged; Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Pilot Projects; Stem Cell Transplantation; Steroids; Transplantation, Homologous; Zoledronic Acid | 2009 |
Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
Topics: Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Double-Blind Method; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Hypocalcemia; Imidazoles; Infusions, Intravenous; Liver Failure; Liver Transplantation; Osteoporosis; Parathyroid Hormone; Zoledronic Acid | 2006 |
7 other study(ies) available for zoledronic acid and Chronic Disease
| Article | Year |
|---|---|
[Severe therapy refractive osteoporosis : A rare differential diagnosis].
Topics: Adult; Anti-Inflammatory Agents; Bone Density Conservation Agents; Chronic Disease; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Rare Diseases; Treatment Failure; Treatment Outcome; Zoledronic Acid | 2016 |
Dual antiplasmodial activity of vitamin D3 and its analog, 22-oxacalcitriol, by direct and indirect mechanisms.
Topics: Acute Disease; Animals; Antimalarials; Body Weight; Calcitriol; Cholecalciferol; Chronic Disease; Diphosphonates; Erythrocytes; Humans; Hypercalcemia; Imidazoles; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Knockout; Parasitemia; Plasmodium chabaudi; Receptors, Calcitriol; Zoledronic Acid | 2017 |
[Zoledronic acid for bone metastases due to advanced renal cell carcinoma under chronic hemodialysis--a report of two cases].
Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Carcinoma, Renal Cell; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Infusions, Intravenous; Interleukin-2; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle Aged; Monitoring, Physiologic; Renal Dialysis; Thalidomide; Zoledronic Acid | 2008 |
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
Topics: Aged; Alcohol Drinking; Alendronate; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic Disease; Clindamycin; Cohort Studies; Combined Modality Therapy; Debridement; Diphosphonates; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Imidazoles; Jaw Diseases; Male; Oral Fistula; Osteonecrosis; Pamidronate; Penicillins; Prospective Studies; Remission Induction; Risk Factors; Smoking; Tooth Extraction; Treatment Outcome; Wound Healing; Zoledronic Acid | 2010 |
Effects of zoledronate in the repair of chronically infarcted rat myocardium.
Topics: Animals; Chronic Disease; Diphosphonates; Female; Heart; Imidazoles; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Zoledronic Acid | 2010 |
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bone Density Conservation Agents; Carcinoma; Chronic Disease; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Maxillary Sinusitis; Middle Aged; Osteonecrosis; Osteoporosis; Osteotomy; Recurrence; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2011 |
Summaries for patients. Zolendronic acid prevents bone loss after liver transplantation.
Topics: Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Double-Blind Method; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Liver Failure; Liver Transplantation; Osteoporosis; Zoledronic Acid | 2006 |